Fluent

Fluent P/B

Delisted

The P/B (Price-to-Book Ratio) of Fluent (TIUM.U.CN) as of Nov 5, 2026 is 2.50. In the previous year, P/B (Price-to-Book Ratio) was 0.78 — a change of 221.03% (higher).

P/B

2.50

YoY

221.03%

Last updated:

P/B (Price-to-Book Ratio) of Fluent is 2023 2.50 . P/B (Price-to-Book Ratio) of Fluent was 2022 0.78 . It decreases by 221.03% higher compared to the previous year.

The Fluent P/B history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/B
Date
P/B
Jan 1, 2019
0.45 USD
Jan 1, 2020
0.77 USD
Jan 1, 2021
0.34 USD
Jan 1, 2022
0.78 USD
Jan 1, 2023
2.50 USD
The Fluent P/B history
YEARP/BYoY
2.50+221.03%
0.78+127.02%
0.34-55.52%
0.77+70.09%
0.45—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Fluent Stock analysis

What does Fluent do? Fluent Corp operates under the private label Fluent, selling medical cannabis products in Florida, Texas, and Pennsylvania. The company's products include oral drops, capsules, suppositories, topicals, syringes, dried flower, pre-rolls, cartridges, edibles, and accessories. Subsidiaries such as Cansortium Holdings LLC and Cansortium Florida, LLC handle production and sales, while Fluent Servicing, LLC manages servicing aspects. The company's revenue comes from direct sales of medical cannabis products through its licensed operations in multiple states. Fluent Corp's target customers are patients seeking medical cannabis treatments, with products tailored to various consumption methods. The company leverages its subsidiaries to maintain compliance and expand its market reach across different states. Sales are conducted through licensed dispensaries and medical cannabis programs, focusing on the healthcare segment of the cannabis industry. The business model relies on the production and sale of medical cannabis under the private label Fluent, utilizing subsidiaries to manage state-specific operations. Products are distributed through established medical cannabis channels, with no mention of additional revenue streams beyond product sales. The company's focus remains on the medical cannabis market, serving patients in Florida, Texas, and Pennsylvania. Fluent is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Fluent stock

P/B (Price-to-Book Ratio) of Fluent is 2.50 in 2023.

P/B (Price-to-Book Ratio) of Fluent changed from 0.78 to 2.50, representing a 221.03% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) Fluent since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s Fluent with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Fluent

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Fluent